Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

TNF-alpha inhibitors can cause various immune-related skin issues.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The model and estimator can predict drug exposure in kidney transplant patients well.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Baricitinib improved hair loss and arthritis in a lupus patient.

Smart microneedles using advanced tech could improve psoriasis treatment.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Anti-CD19 therapy may help treat SLE and NMOSD.

Belimumab may cause hair loss in lupus patients.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.